Elsevier Inc.

SHERPA: Unknown

People

  1. Jones
    Jones
  2. Adusumilli
    Adusumilli
  3. Travis
    Travis
  4. Sadelain
    Sadelain
  5. Arcila
    Arcila
  6. Kris
    Kris
  7. Park
    Park
  8. Rusch
    Rusch
  9. Zauderer
    Zauderer
  10. Chaft
    Chaft

Groups

  1. Surgery (13)
  2. Department of Medicine (8)
  3. Sloan Kettering Institute Postdocs (8)
  4. Center for Hematologic Malignancies (5)
  5. GSK Faculty (5)
  6. Hematologic Malignancies Research (5)
  7. Hematologic Malignancies, Division of (5)
  8. Molecular Pharmacology and Chemistry Program Faculty (5)
  9. Sloan Kettering Institute Faculty (5)
  10. Solid Tumor Oncology Division (3)
Search Within
  1. "2015"
  2. "David Jones"
Formats
  1. Meeting Abstract (11)
  2. Journal Article (2)
Groups
  1. Surgery (13)
  2. Department of Medicine (8)
  3. Sloan Kettering Institute Postdocs (8)
  4. Center for Hematologic Malignancies (5)
  5. GSK Faculty (5)
  6. Hematologic Malignancies Research (5)

More Groups

People
  1. David Jones (13)
  2. Prasad Adusumilli (10)
  3. William Travis (7)
  4. Camelia Sima (5)
  5. Kaitlin Woo (5)
  6. Marissa Mayor (5)

More People

Years
  1. 2015 (13)
Publications
  1. Journal of Thoracic Oncology (13)

Results (13)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targetable cancer-associated antigens for immunotherapy in malignant pleural mesothelioma (MPM) — Mesothelin, CA125 and WT-1
    Meeting Abstract

    Ujiie, H.; Eguchi, T.; Mayor, M.; Kadota, K.; Travis, W. D.; Jones, D. R.; Sadelain, M.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Genetic-engineering strategies to enhance CAR T-cell therapy efficacy against PD-L1 expressing lung adenocarcinoma and mesothelioma
    Meeting Abstract

    Cherkassky, L.; Morello, A.; Villena-Vargas, J.; Mayor, M.; Jones, D. R.; Sadelain, M.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Occult primary non-small cell lung cancer with mediastinal lymph node involvement
    Meeting Abstract

    Romesser, P. B.; Rimner, A.; Foster, A.; Chaft, J. E.; Huang, J.; Jones, D. R.; Wu, A. J.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • HNF4 α is a marker for invasive mucinous adenocarcinoma (IMA) and a prognostic factor in stage I lung adenocarcinoma (LADC)
    Meeting Abstract

    Eguchi, T.; Kadota, K.; Leduc, C.; Rekhtman, N.; Moreira, A.; Jones, D. R.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Diagnostic molecular testing in multiple lung cancers
    Meeting Abstract

    Naidoo, J.; Woo, K.; Sima, C. S.; Travis, W. D.; Arcila, M. E.; Finley, D. J.; Rusch, V.; Jones, D. R.; Kris, M. G.; Zauderer, M. G.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Long and short-term predictors of outcome in elderly patients (>= 75 years) undergoing lobectomy for stage I non-small cell lung cancer
    Meeting Abstract

    Eguchi, T.; Buitrago, D. H.; Mayor, M.; Kadota, K.; Rizk, N. P.; Park, B. J.; Jones, D. R.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • T1a lung adenocarcinomas: Presence of spread of tumor through alveolar spaces (STAS), micropapillary and solid patterns determines outcomes
    Meeting Abstract

    Kadota, K.; Eguchi, T.; Rizk, N. P.; Woo, K. M.; Sima, C. S.; Park, B. J.; Jones, D. R.; Travis, W. D.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Multiple lung cancers: Is their survival better or worse then other lung cancers?
    Meeting Abstract

    Naidoo, J.; Woo, K.; Sima, C. S.; Travis, W. D.; Arcila, M.; Finley, D. J.; Rusch, V. W.; Jones, D. R.; Kris, M. G.; Zauderer, M.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Mesothelin-targeted CAR T-cell therapy for the treatment of heterogeneous antigen-expressing lung adenocarcinoma
    Meeting Abstract

    Morello, A.; Villena-Vargas, J.; Mayor, M.; Bograd, A. J.; Jones, D. R.; Sadelain, M.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Tumor-targeted radiation therapy helps overcome the solid tumor T-cell infiltration barrier and promotes mesothelin CAR T-cell therapy
    Meeting Abstract

    Mayor, M.; Villena-Vargas, J.; De Biasi, A.; Morello, A.; Jones, D. R.; Sadelain, M.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save